As a junior dental student at The Ohio State University College of Dentistry, your editor had the rather unique opportunity to provide intravenous moderate sedation for dental phobic patients for restorative dentistry under the supervision of the late Dr N. Wayne Hiatt, an American Dental Society of Anesthesiology past president and Heidbrink Award winner, and another part-time general dentist, Dr Raymond D. Johnston. Although we used a combination of pentobarbital, promethazine, and meperidine, Dr Hiatt had become intrigued in his private practice of general dentistry by a newly-approved intravenous drug called diazepam (Valium). In my senior year, I had the